A prospective observational study on safety and efficacy of metformin and its combination used in type-ii diabetes mellitus patients

G. M, Jahnavi S, Reena Priyadarshini G, Swathi Priya K, Niveditha D
{"title":"A prospective observational study on safety and efficacy of metformin and its combination used in type-ii diabetes mellitus patients","authors":"G. M, Jahnavi S, Reena Priyadarshini G, Swathi Priya K, Niveditha D","doi":"10.37022/wjcmpr.v5i6.310","DOIUrl":null,"url":null,"abstract":"Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. This study was carried out with an objective to determine the efficacy of Metformin with other oral hypoglycemic agents, to educate the patients about the disease and use of drugs in diabetes mellitus and to evaluate which class of drugs in oral hypoglycemic agents with Metformin shows more effectiveness. The patients in each group received the medication for 8 weeks duration. A study was carried out about the comparative, efficacy of glimepiride and metformin in type-2 DM which was a meta-analysis of randomized controlled trials. The results of the study were that metformin alone does not show the efficacy than with Metformin+ Teneligliptin and Metformin + Glimepiride in overall efficacy of controlling FBS and PPBS. Combination of Metformin+ Glimepiride is more effective than Metformin+ Teneligliptin and Metformin alone. The findings from the study observed the combination of metformin efficacy to some extent.","PeriodicalId":23642,"journal":{"name":"World Journal of Current Medical and Pharmaceutical Research","volume":"161 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Current Medical and Pharmaceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37022/wjcmpr.v5i6.310","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. This study was carried out with an objective to determine the efficacy of Metformin with other oral hypoglycemic agents, to educate the patients about the disease and use of drugs in diabetes mellitus and to evaluate which class of drugs in oral hypoglycemic agents with Metformin shows more effectiveness. The patients in each group received the medication for 8 weeks duration. A study was carried out about the comparative, efficacy of glimepiride and metformin in type-2 DM which was a meta-analysis of randomized controlled trials. The results of the study were that metformin alone does not show the efficacy than with Metformin+ Teneligliptin and Metformin + Glimepiride in overall efficacy of controlling FBS and PPBS. Combination of Metformin+ Glimepiride is more effective than Metformin+ Teneligliptin and Metformin alone. The findings from the study observed the combination of metformin efficacy to some extent.
关于二甲双胍及其复方制剂用于 II 型糖尿病患者的安全性和有效性的前瞻性观察研究
糖尿病是由于胰腺不能产生足够的胰岛素,或者人体细胞对所产生的胰岛素不能做出适当的反应。开展这项研究的目的是确定二甲双胍与其他口服降糖药的疗效,向患者宣传糖尿病的疾病和用药知识,并评估二甲双胍与哪一类口服降糖药更有效。每组患者接受为期 8 周的药物治疗。一项关于格列美脲和二甲双胍对 2 型糖尿病疗效比较的研究是对随机对照试验的荟萃分析。研究结果表明,在控制 FBS 和 PPBS 的总体疗效方面,单独使用二甲双胍的疗效不如二甲双胍+替尼利汀和二甲双胍+格列美脲。二甲双胍+格列美脲联合用药比二甲双胍+替格列汀和二甲双胍单独用药更有效。研究结果表明,二甲双胍联合用药在一定程度上具有疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信